David A. Putnam
Drug delivery; vaccine design and development; biomaterials design and synthesis
Current Research Interest
Surgical biomaterials; biomimetic joint lubricants; targeted delivery of anticancer drugs; immuno-engineering with specific focus in vaccines design
American Institute for Medical and Biological Engineering Fellow
Coulter Foundation Fellow
National Science Foundation CAREER Award
Founder/Cofounder of Versatope Therapeutics Inc., ProVis Medical Inc., Articulate Biomedical LLC, and TransForm Pharmaceuticals Inc.
Watkins, Hannah C., Catalina L. Pagan, Hannah R. Childs, Sara Posada, Annie Chau, Jose Rios, Cassandra Guarino, et al. “A Single Dose and Long Lasting Vaccine against Pandemic Influenza through the Controlled Release of a Heterospecies Tandem M2 Sequence Embedded within Detoxified Bacterial Outer Membrane Vesicles.” Vaccine 35, no. 40 (2017): 5373–80.
Watkins, Hannah C., C. Garrett Rappazzo, Jaclyn S. Higgins, Xiangjie Sun, Nicole Brock, Annie Chau, Aditya Misra, et al. “Safe Recombinant Outer Membrane Vesicles that Display M2e Elicit Heterologous Influenza Protection.” Molecular Therapy 25, no. 4 (2017): 989–1002.